British laughs for the first time in the fight against mutant corona

British Prime Minister Boris Johnson laughs during a COVID-19 briefing held at the Prime Minister's residence at 10 Downing Street in London on the 3rd (local time).[AFP=연합뉴스]

British Prime Minister Boris Johnson laughs during a COVID-19 briefing held at the Prime Minister’s residence at 10 Downing Street in London on the 3rd (local time).[AFP=연합뉴스]

Hopeful signs have begun to appear in Britain, which has been struggling with the COVID-19 mutant virus.

90% of the elderly aged 75 and over in the UK
The number of new infected people decreased by 25% compared to the previous week

According to local media such as the BBC on the 3rd (local time), British Prime Minister Boris Johnson and government medical advisers said, “The (proliferation tax) peak has passed” at a briefing held at the Prime Minister’s residence that day.

“We hope that schools in England will be able to open on March 8, as evidence appears that the vaccine has reduced deaths and severely ill patients,” Johnson said. In the UK, 10 million people, or 90% of the population aged 75 and over, have completed the first dose of the vaccine.

25% reduction in the number of infected people over a week

British Health Minister Matt Hancock laughs at the British Parliament's inquiry into the Corona 19 government on the 2nd (local time).[로이터=연합뉴스]

British Health Minister Matt Hancock laughs at the British Parliament’s inquiry into the Corona 19 government on the 2nd (local time).[로이터=연합뉴스]

The day before, the number of confirmed cases in England was 19,202 and 1,322 deaths. The cumulative death toll is 1093,335. The independent During the last 7 days, the number of new infections decreased by more than 25% compared to the previous week, and deaths during this period also decreased by 13.4% compared to the previous week.

“The number of patients and deaths admitted to hospitals has decreased considerably,” said Dr. Chris Whitty, chief medical adviser in the UK.

However, Dr. Whitty said, “It is an important problem that there are still many infected people.”

“The level of infection is still surprisingly high,” said Prime Minister Johnson. “People who have completed the secondary vaccination should also follow the rules of distancing.”

According to Our World In Data, a statistical website operated by Oxford University in the UK on the 3rd (local time), the UK is ranked third after Israel and the UAE with a vaccination rate of 14.9%.

According to Our World In Data, a statistical website operated by Oxford University in the UK on the 3rd (local time), the UK is ranked third after Israel and the UAE with a vaccination rate of 14.9%.

In the UK, 1,121,471 people have completed the first vaccination by this day. The number of British citizens who completed the second vaccination was 49,8962.

According to OurWorld In Data, a statistical site operated by researchers at Oxford University in the UK, the vaccination rate in the UK (14.9%) on the 2nd is the third after Israel (58.8%) and the United Arab Emirates (34.8%). Bahrain (10.2%) followed by the US (9.8%).

On the 3rd (local time), a homeless man in eastern London gets AstraZeneca vaccine.[AFP=연합뉴스]

On the 3rd (local time), a homeless man in eastern London gets AstraZeneca vaccine.[AFP=연합뉴스]

The US also beats the spread, “the speed of vaccine supply is key”

Anthony Pouch Director of the National Institute of Allergy and Infectious Diseases (NIAID). [AP=연합뉴스]

Anthony Pouch Director of the National Institute of Allergy and Infectious Diseases (NIAID). [AP=연합뉴스]

Meanwhile, the Centers for Disease Control and Prevention (CDC) also announced that the number of infected patients and hospitalized patients is decreasing.

The key is the speed of vaccine supply in the future. Anthony Pouch, director of the National Institute of Allergies and Infectious Diseases (NIAID), told NBC that day, when asked, “Is vaccination fast enough to precede the spread of the mutant virus?” he answered, “It is still not possible to do so.” “Because they are ahead of them,” he said.

However, it positively evaluated the news of the White House’s decision to supply vaccines to pharmacies across the United States, and predicted that “it will improve gradually.”

In an interview with Axios, the CEO of Modena, a US pharmaceutical company, said, “We will launch the next vaccine against mutations on a large scale.”

Reporter Jeong Eun-hye [email protected]


Source